1.) As of today, there are now 158.1M + 35.7M = 193.8M shares outstanding, with today adding 22.6% more dilution … its now basically doubled over the course of the past year!!! 2.) The Liquid Surfaxin is the Lead Program, and it is targeted to a $75M/yr U.S.-only market opportunity, which is currently served by [...]
{ 0 comments }